<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04505475</url>
  </required_header>
  <id_info>
    <org_study_id>01-11/45-2015 DCV</org_study_id>
    <nct_id>NCT04505475</nct_id>
  </id_info>
  <brief_title>Oral Surgery in Patients Taking Direct Oral Anticoagulants</brief_title>
  <acronym>OSDOA</acronym>
  <official_title>Oral Surgery in Patients Taking Direct Oral Anticoagulants and Vitamin K Antagonists</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Novi Sad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Novi Sad</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the incidence of postoperative bleeding after oral surgical procedures&#xD;
      in patients taking direct oral anticoagulants and in patients taking vitamin K antagonists.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin K antagonists (VKA) are widely used in long term prevention and treatment of&#xD;
      thromboembolism. In the last few years direct oral anticoagulants (DOACs) are available for&#xD;
      clinical use, mostly in prevention of stroke and systemic embolisms in patients with&#xD;
      nonvalvular atrial fibrillation, and prevention and treatment of venous thrombosis. Numerous&#xD;
      studies confirmed that minor oral surgical procedures in patients taking VKA with therapeutic&#xD;
      (International Normalized Ratio) INR levels can be safely performed without therapy&#xD;
      interruption if proper local haemostatic measures are applied. Similar recommendations were&#xD;
      given for the dental treatment of patients taking DOACs, but there is a lack of clinical&#xD;
      studies. The aim of this study is to assess the incidence of bleeding complications after&#xD;
      oral surgery in patients who continue their DOACs or VKA medications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 25, 2015</start_date>
  <completion_date type="Actual">August 3, 2020</completion_date>
  <primary_completion_date type="Actual">August 3, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative bleeding event</measure>
    <time_frame>7 days</time_frame>
    <description>Bleeding that requires additional surgical procedure</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">82</enrollment>
  <condition>Anticoagulants and Bleeding Disorders</condition>
  <condition>Surgery</condition>
  <condition>Postoperative Hemorrhage</condition>
  <condition>Dentoalveolar Haemorrhage</condition>
  <arm_group>
    <arm_group_label>Direct oral anticoagulants</arm_group_label>
    <description>Patients taking dabigatran, ravaroxaban or apixaban</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin K antagonists</arm_group_label>
    <description>Patients taking acenocoumarol with therapeutic INR levels (2.0-3.5)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oral surgical procedure followed by local hemostatic measures (insertion of gelatine sponge and wound suturing)</intervention_name>
    <description>single and multiple teeth extraction, surgical tooth extraction, third molar surgery, gingivectomy, soft-tissue biopsy</description>
    <arm_group_label>Direct oral anticoagulants</arm_group_label>
    <arm_group_label>Vitamin K antagonists</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study includes patients taking direct oral anticoagulants (DOACs) and patients taking&#xD;
        vitamin K antagonists (VKA) who require oral surgical procedure. The groups will be matched&#xD;
        with respect to oral surgical procedure i.e. operative trauma.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female patients over 18 years&#xD;
&#xD;
          -  Patients taking regularly direct anticoagulant therapy: dabigatran, rivaroxaban or&#xD;
             apixaban (DOACs group)&#xD;
&#xD;
          -  Patients taking regularly acenocoumarol with INR 2.0-3.5 on the day of the surgery&#xD;
             (VKA group)&#xD;
&#xD;
          -  Indication for oral surgical procedure&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Liver or renal disease&#xD;
&#xD;
          -  Coagulopathy&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Allergy to lidocaine&#xD;
&#xD;
          -  Patients who stopped taking their anticoagulant medication&#xD;
&#xD;
          -  Patients taking VKA with INR &lt;2.0 or &gt;3.5 on the day of the procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Branislav Bajkin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Novi Sad, Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dental Clinic of Vojvodina</name>
      <address>
        <city>Novi Sad</city>
        <state>Vojvodina</state>
        <zip>21000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 5, 2020</study_first_submitted>
  <study_first_submitted_qc>August 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2020</study_first_posted>
  <last_update_submitted>August 10, 2020</last_update_submitted>
  <last_update_submitted_qc>August 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Novi Sad</investigator_affiliation>
    <investigator_full_name>Branislav Bajkin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>oral anticoagulants</keyword>
  <keyword>dabigatran</keyword>
  <keyword>rivaroxaban</keyword>
  <keyword>warfarin</keyword>
  <keyword>oral surgery</keyword>
  <keyword>hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Postoperative Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

